MELISSA CONNELLY: Open Payments
NPI 1730545534 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 15 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $197 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $124 |
| ABBVIE INC. | 4 | $77 |
| PFIZER INC. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Biogen, Inc. | 1 | $28 |
| ARGENX US, INC. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
Products named: KISUNLA, NURTEC ODT, BOTOX, AUSTEDO XR, QULIPTA, VUMERITY, VYVGART HYTRULO, AMYVID.
Industry payments across IA — which companies pay providers there.
